GlaxoSmithKline Oncology CASE PhD Scholarship
GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies, with a challenging and inspiring mission; to improve the quality of human life by enabling people to do more, feel better and live longer.
At GSK we recognise that collaborations with academic researchers are a vital component of our R&D activities. Working together can help us to advance our scientific understanding in key therapeutic areas and facilitate the rapid discovery and development of new medicines for patients.
In 2011, GSK launched a PhD Scholarship programme in the field of oncology/haematology to demonstrate our commitment to working in partnership with the academic community.
The aim of the GSK Oncology CASE PhD Scholarship is to provide an opportunity for academic collaboration and offer a first class training experience in an industrial environment within the setting of GSK Oncology R&D.
We are delighted to announce that we will be offering a further oncology scholarship this year to commence in October 2013.
PhD supervisors are invited to submit proposals in the following areas:
- Cancer epigenetics
- Tumour metabolism
- Rational combination therapies
- Unfolded protein response
- Protein degradation pathways
- Immunomodulatory therapies
- Cancer cell surface antigens
The recipient of the 2011 award was Dr Melania Capasso from The Barts Cancer Institute in London for her research proposal on lymphoma treatment.
"It is vital to increase collaborations between Industry and Academia since we can all benefit from each other's expertise. The GSK Oncology CASE studentship provided the perfect opportunity and this is the reason why I applied last year. I was also attracted by the straightforward application process… and the unique opportunity to discuss my project with eminent scientists on the panel was an added bonus."
The proposal submission form can be downloaded here.
The completed form should then be submitted by email to firstname.lastname@example.org by 31 August 2012.
Proposals will be reviewed by GSK R&D in the first instance and subsequently evaluated by an independent panel of leading UK oncology experts.
Shortlisted applicants will be invited to present their proposals to the panel on 29 November 2012 in London where the successful candidate will be selected.
The student fulfilling the PhD Scholarship will be a scientist and they will need to meet the studentship eligibility criteria set out by the UK Research Council. The scholarship will cover a PhD stipend and consumables. In addition it will provide the opportunity for the student to spend at least 3 months conducting their PhD at the GSK oncology research laboratories in Pennsylvania, USA.